Continuous and intermittent levamisole. A controlled trial
- PMID: 356761
- PMCID: PMC1000218
- DOI: 10.1136/ard.37.3.259
Continuous and intermittent levamisole. A controlled trial
Abstract
A double-blind comparative trial showed that intermittent levamisole therapy (150 mg daily for 3 days of each week) was as effective as continuous therapy (150 mg daily) in rheumatoid arthritis and with slightly fewer side effects.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
